Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 762,557 shares of the company’s stock after acquiring an additional 15,266 shares during the quarter. Charles Schwab Investment […]
More Stories
ICE Agent Shot, Killed Protester Who Drove Vehicle Toward Officers in Minnesota: DHS
By Jacki Thrapp A U.S. Immigration and Customs Enforcement officer in Minnesota shot and killed an anti-ICE protester during an...
A New Dawn for Venezuela: How the Capture of Nicolás Maduro Paves the Way for Prosperity, Justice, and Global Stability
By Stephen Zogopoulos, USNN World News In a bold and decisive move that has reshaped the geopolitical landscape of the...
With GDP up 4.3%, 5% Gains Are Likely in 2026
By Louis Navellier Commentary My 5% GDP growth prediction raised some eyebrows during a recent appearance on Fox Business News. However,...
After Maduro’s Arrest, CCP Censors Let Anti-American Hatred Spread Online—By Design: Analysts
By Michael Zhuang News Analysis After U.S. special forces captured Venezuelan leader Nicolás Maduro to stand trial in federal court,...
The Truth About Venezuela Under Socialism, From Those Who Fled It
By Troy Myers DORAL, Fla.—Zarai Maza survived a torched vehicle and a horrific car crash after peacefully protesting the Venezuelan...
DOJ Sues Arizona, Connecticut for Failing to Hand Over Voter Rolls
By Matthew Vadum The U.S. Department of Justice (DOJ) said on Jan. 6 that it is suing Arizona and Connecticut...